Anxiolytic properties of Piper methysticum extract samples and fractions in the chick social-separation-stress procedure
- PMID: 12672148
- DOI: 10.1002/ptr.1107
Anxiolytic properties of Piper methysticum extract samples and fractions in the chick social-separation-stress procedure
Abstract
Piper methysticum extract (Kava kava) possesses anxiolytic properties. However, it is unknown whether these effects are best predicted by total kavalactone content or by one or more of its primary kavalactone constituents. Using the chick social separation-stress procedure as an anxiolytic bioassay, P. methysticum samples containing 12.8-100.0% total kavalactones (Exp. 1) and fractions containing 1-6 kavalactones of varying concentrations (0.1-67.5%; Exps. 2-3) were screened for activity and compared against a 5.0 mg/kg dose of chlordiazepoxide (CDP; Exp. 3). Eight-day-old chicks received IP injections of either vehicle or test compounds 30 min before being placed in the presence of two conspecifics or in isolation for a 3 min observation period. Dependent measures were ventral recumbency latency (sedation), distress vocalizations, and a measure of stress-induced analgesia (in Exps. 1 and 2 only). P. methysticum extract samples attenuated distress vocalizations in a concentration-dependent manner. The P. methysticum fraction that contained the highest concentration of dihydrokavain attenuated distress vocalizations in a manner equivalent to that of CDP. The extract samples and fractions that possessed anxiolytic properties did not possess the sedative properties found in CDP. Collectively, these findings suggest that dihydrokavain may be necessary and sufficient in mediating the anxiolytic properties of P. methysticum extract.
Copyright 2003 John Wiley & Sons, Ltd.
Similar articles
-
Anxiolytic effects of kava extract and kavalactones in the chick social separation-stress paradigm.Psychopharmacology (Berl). 2001 Apr;155(1):86-90. doi: 10.1007/s002130100686. Psychopharmacology (Berl). 2001. PMID: 11374340
-
Extracts and kavalactones of Piper methysticum G. Forst (kava-kava) inhibit P-glycoprotein in vitro.Drug Metab Dispos. 2005 Nov;33(11):1580-3. doi: 10.1124/dmd.105.005892. Epub 2005 Jul 28. Drug Metab Dispos. 2005. PMID: 16051732
-
Discriminative-stimulus and time-course effects of kava-kava (Piper methysticum) in rats.Pharmacol Biochem Behav. 2009 Apr;92(2):297-303. doi: 10.1016/j.pbb.2008.12.017. Epub 2008 Dec 31. Pharmacol Biochem Behav. 2009. PMID: 19159643
-
Pharmacokinetic and pharmacodynamic drug interactions with Kava (Piper methysticum Forst. f.).J Ethnopharmacol. 2004 Aug;93(2-3):153-60. doi: 10.1016/j.jep.2004.04.009. J Ethnopharmacol. 2004. PMID: 15234747 Review.
-
Kava: a comprehensive review of efficacy, safety, and psychopharmacology.Aust N Z J Psychiatry. 2011 Jan;45(1):27-35. doi: 10.3109/00048674.2010.522554. Epub 2010 Nov 15. Aust N Z J Psychiatry. 2011. PMID: 21073405 Review.
Cited by 6 articles
-
Intracerebroventricular Injection of L-Pipecolic Acid Exerts Hypnotic Effects Without Activating NMDA Receptors in Neonatal Chicks under Social Isolation-induced Stress.J Poult Sci. 2020 Jan 25;57(1):84-87. doi: 10.2141/jpsa.0190067. J Poult Sci. 2020. PMID: 32174769 Free PMC article.
-
A stable isotope dilution tandem mass spectrometry method of major kavalactones and its applications.PLoS One. 2018 May 24;13(5):e0197940. doi: 10.1371/journal.pone.0197940. eCollection 2018. PLoS One. 2018. PMID: 29795658 Free PMC article.
-
Cell and small animal models for phenotypic drug discovery.Drug Des Devel Ther. 2017 Jun 28;11:1957-1967. doi: 10.2147/DDDT.S129447. eCollection 2017. Drug Des Devel Ther. 2017. PMID: 28721015 Free PMC article. Review.
-
An overview of the evidence and mechanisms of herb-drug interactions.Front Pharmacol. 2012 Apr 30;3:69. doi: 10.3389/fphar.2012.00069. eCollection 2012. Front Pharmacol. 2012. PMID: 22557968 Free PMC article.
-
Euphorbia hirta reverses chronic stress-induced anxiety and mediates its action through the GABA(A) receptor benzodiazepine receptor-Cl(-) channel complex.J Neural Transm (Vienna). 2008;115(1):35-42. doi: 10.1007/s00702-007-0821-6. Epub 2007 Dec 18. J Neural Transm (Vienna). 2008. PMID: 18087670
Publication types
MeSH terms
Substances
LinkOut - more resources
-
Full Text Sources
-
Other Literature Sources
-
Medical
